Asset profile
SER-252 · Serina Therapeutics, Inc. (SER)
- Indication
- advanced Parkinson’s disease
- Also known as
- POZ-apomorphine
Company
SERSerina Therapeutics, Inc.
SERSerina Therapeutics, Inc.Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading …
On the calendar
Nothing scheduled in this window.
Timeline
Newest first.
Minor
Mar 23, 2026
08:07 PM
SERSerina Therapeutics, Inc.Serina raises $30 M private placement to fund SER-252 registrational trial